Political prohibition of drugs devours its children

The Saturn myth portrayed in Ovid’s poem Fasti is about a ruler so terrified of losing power he destroys his own children to protect it. His brutal act violates the duties and expectations of a regime that tries to preserve itself by annihilating itself and its future from within. No better example exists than the kinds of despotism emerging from a drug war: fear, instability, more fear, further repression, and ultimately the collapse of a ruler’s legitimacy.

It’s no surprise the drug war is driven by its own delusional prophesies of doom. The doomsayers’ common themes proclaim that alcohol will destroy society, that drugs will collapse civilizations, that drug users are inherently dangerous, and that addiction is a moral epidemic rather than a treatable medical problem.

Public policies can do harm to civil liberties, public trust, institutional legitimacy, and the wellbeing of common citizens. In his latest book, Rage and the Republic: The Unfinished Story of the American Revolution, Jonathan Turley employs what he calls the Saturn gene to explain how revolutions and political movements can mutate into the kind of autocracy that guarantees their failure:

It is a story played out over and over again in history as ambition becomes activism, activism becomes extremism, and extremism becomes authoritarianism. Call it the Saturn gene. We are all Saturn’s children with an inherent impulse that rests within each of us: the capacity of all mortals to become monsters. – Jonathan Turley, p. xvi, Rage and Republic, 2026.

Sources of drug war harm include the criminalizing of millions—especially young people, thereby feeding mass incarceration, destabilizing families, communities, and generating violence through black markets.

The drug war erodes trust in government by incentivizing corruption in police and courts, by creating law enforcement systems that violate civil liberties, and by producing outcomes in opposition to stated goals, such as creating more dangerous drug substances, more violence, false arrests, and SWAT-style home invasions in which innocent people that can include police officers sometimes die.

Prohibition policies sacrifice future generations by criminalizing youths and adults for minor drug possession, thereby creating lifelong barriers to employment, housing, education, and complicating intergenerational family relationships in communities targeted by drug law enforcement. It creates harsh penalties, militarized policing, mandatory minimums, added surveillance programs and asset forfeitures.

Prohibition is pictured as having begun with noble aspirations. In certain cases the stated objective of drug enforcement policies appears to have provided a plausible disguise for motives driven by the types of politics generated when a society combines moral profiteering with the behaviors associated with a Saturn gene which evolved as part of the sociobiology of genetically sourced xenophobia and nationalism.

The perceived legitimacy of the drug war continues to collapse at an accelerating rate. It collapses a bit more each day researchers learn something new about how the brain works, or how certain drugs affect the brain at the molecular level and at the levels of conscious awareness.

Future use of mind tripping drugs will aid in encouraging the development of new technologies, new therapies, and better public policies. It’s already happening. Citizens will want to celebrate their good fortune by recognizing a new era of drug liberty where minds are set free to thrive and evolve. Political leaders who believe in absurdities will continue to commit atrocities, but the drug war will become obsolete – no longer at anyone’s disposal as a convenient political tool. Maybe best of all, never again will people be compelled to feel guilty about feeling good.

This entry was posted in Servetus. Bookmark the permalink.

6 Responses to Political prohibition of drugs devours its children

  1. Carlyle Moulton says:

    The worst addiction for most members of species so called “homo sapiens” is to moralizing. Hypocrisy and moralizing always occur together because their respective Goddesses in the Pantheon are conjoined twins. Hostility to users of mind altering chemicals deemed illegal is not because they do harm but because the subsequent actions by the agents of Laura Norder do harm and it is wrongly attributed to drugs and those who use them.

    Complex social problems do not have simple single causes. Behind them instead are complex networks of causal elements which have to be analyzed before one can begin thinking about trying remedies. There are sets of causes in series where one may be a better candidate for attack than others, sets of causes in parallel where any intervention on some only will be ineffective. There are also positive and negative feedback loops and damping the positive and enhancing the negatives are possible targets. This firs requires a sufficiently accurate causal model and if a white board were used to diagram it out its size would need to measure hundreds of square kilometres. Then after identifying potential target elements to attack trial and error interventions would be needed. Some of these would fail.

    The majority of humans are not intelligent enough to do this analysis nor to realize the true complexity of the causes and will focus on knee jerk solutions like punishing bad people or spending more on prohibition. Our standard method for changing behavior of people perceived to be bad is punishment but it does not work because “good” and “bad” people do not respond to it in the same way. It may work for those who see their punishment as deserved but it does not work on those society agrees are bad, they perceive it as discrimination and as anger and rage figure prominently in their personal behaviour it makes them worse.

    Some people, criminologists, social workers and some more than averagely intelligent former police advise trying to rehabilitate the underclasses on the basis that the money needed would lessen spending on courts, police and prisons but 99% of homo sapiens reject this because it is contradictory to analysis by morally adjusted cost benefit ratios. When comparing expenditure on doing good and harm to bad people the moral ones use morally adjusted numbers. Fudge factors are applied before the comparison, Let’s assume a fudge factor of 10. Then each dollar spent doing good to “bad” people is counted as $10.00 and each dollar making them miserable counted as $0.10. Obviously $0.10 is much cheaper than $10.00 so there is NO WAY such advice will be heeded!!!

  2. Servetus says:

    Study challenges belief that women are more sensitive to the effects of cannabis:

    5-Nov-2026 — Men who use cannabis occasionally reacted more strongly to smoked cannabis than women with similar use habits, even though the amount of THC in their blood was about the same, according to a new study from UCLA Health. The findings run counter to earlier research suggesting that women are more sensitive to cannabis. […]

    In three separate sessions, each participant smoked placebo, lower-THC and higher-THC cannabis without knowing which they had received. Women in the study were not using hormonal birth control and were tested during the same phase of their menstrual cycle. The analysis found:

    Men who used cannabis occasionally reported feeling more high, sedated and impaired than other participants, along with more unpleasant effects such as anxiety. They were also the only group whose heart rate rose significantly after smoking active cannabis.
    Women and men who used cannabis frequently responded to it in similar ways.

    Regardless of sex, people who used frequently exhibited the addictive qualities of cannabis more than those who used occasionally.

    Blood THC levels did not explain the differences. Men who used frequently tended to have the highest THC levels, yet they felt fewer effects than men who used occasionally.

    “Much of what we thought we knew about sex differences in cannabis effects came from animal research and from human studies that pooled data from different trials,” said Dr. Ziva Cooper, the study’s principal investigator and director of the UCLA Center for Cannabis and Cannabinoids. “When we designed a study to look at sex and frequency of use at the same time, and controlled for hormones, the picture changed. As more women use cannabis, including for women’s health conditions, we need evidence from studies designed to include them.” […]

    AAAS Public Science News Release: UCLA study challenges belief that women are more sensitive to the effects of cannabis — findings show men who used cannabis occasionally experienced stronger effects than women with similar use habits

    Neuropsychopharmacology: Sex- and frequency-dependent acute pharmacokinetic and pharmacodynamic effects of smoked cannabis: a randomized controlled trial

    Authors: Stephanie Lake, Elisa Pabon, Samantha L. Baglot, Alisha Eversole, Conor H. Murray, Katherine Hampilos, Timothy Fong, Holly Middlekauff, Margaret Haney, Suzette M. Evans, Adren Tran, Alexa Torrens, Daniele Piomelli & Ziva D. Cooper.

  3. Servetus says:

    Direct evidence for psychoactive cannabis use 2800 years ago:

    5-Nov-2026 — Analysis of hair in a 2,800-year-old tomb in Siberia has yielded the earliest direct evidence of psychoactive cannabis use. The findings shed light on the plant’s role in ancient societies. Cannabis – one of the most widely used psychoactive plants in the world – has been consumed for medicinal, recreational, and ritual purposes for thousands of years. However, the origins of the plant’s use, particularly for its mind-altering properties, remain poorly understood; archaeological evidence of ancient consumption is limited by the poor preservation of plant remains. Although cannabis was cultivated in East Asia at least 6,000 years ago, likely initially for its oil-rich seeds, indirect evidence of its use for mind-altering effects dates back at least 2,500 years, including discoveries suggesting its role in funerary and ritual practices across Central Asia. […]

    Radiocarbon dating indicated that the seeds were deposited around the beginning of the 8th century BCE (~2,800 years ago), coinciding with the construction of the burial site. What’s more, human hair was also recovered from the burials. Importantly, chemical analysis of the hair detected cannabinol, a compound produced when THC (the psychoactive compound found in cannabis) oxidizes, alongside weaker chemical signatures consistent with THC itself. According to Caspari et al., the findings provide the earliest securely dated direct evidence supporting the idea that ancient people used cannabis for its mind-altering effects in cultural and ceremonial practices. […]

    AAAS Public Science News Release: Ancient Siberian tomb reveals 2,800-year-old evidence of ritual cannabis use

    Science: Direct evidence for psychoactive cannabis use 2800 years ago

    Authors: Gino Caspari, Timur Sadykov, Daria Fomicheva, Jegor Blochin, Dominic Armbruster, Oliver Happel, Natalia Ryabogina, Kseniia Boxleitner, and Robert Spengler.

  4. Servetus says:

    Idaho penalties for fentanyl possession are rigged to equate quantities of pills with trafficking to justify mandatory minimum sentences for mere possession alone:

    November 5, 2026 — When two Idaho lawmakers pitched harsher penalties for people caught with fentanyl, they said the new law would target drug dealers — not those struggling with addiction.

    But two years after the law was implemented, prosecutors have charged at least 30 people with fentanyl trafficking without presenting evidence that they were dealing or distributing the drug.

    The law, which went into effect on July 1, 2024, does not differentiate between those using and those selling the drug, and it doesn’t require prosecutors to find evidence of trafficking. Instead, prosecutors can charge people with fentanyl trafficking if they possess at least 4 grams or 100 pills that contain fentanyl.

    InvestigateWest reviewed court records for all fentanyl trafficking charges filed through June 30 of this year. Among the 90 cases that included arrest reports, one-third of them lacked evidence such as scales, ledgers and small bags, which when found together are commonly considered proof that someone sold or intended to sell drugs. But court records show those people were charged with trafficking and face the law’s mandatory minimum prison terms based on the amount of fentanyl police said they had. […]

    KTVB 7 News Boise: An Idaho law targeted fentanyl dealers. Prosecutors are using it to charge users, too — since being enacted on July 1, 2024, prosecutors have charged at least 30 people with trafficking without evidence of dealing.

    Author: Whitney Bryen

  5. Servetus says:

    Magic mushrooms rewire the brain in a way scientists didn’t expect:

    November 6, 2026 — A new study …has revealed how psilocybin … changes the brain by reorganizing connections between nerve cells. The findings could eventually help scientists develop treatments for mental health conditions that capture some of psilocybin’s potential benefits without producing hallucinations. […]

    …psilocybin rapidly encourages brain cells to form new connections and helps those connections mature. At the same time, it promotes the removal of certain older connections, suggesting that its effects involve more than simply increasing communication between neurons.

    Experiments in mice also revealed something especially intriguing. The researchers were able to separate the cellular changes responsible for this rewiring from a behavioral response commonly associated with psychedelic effects. This suggests that some of psilocybin’s effects on brain structure may be achievable without the hallucinations typically associated with the drug.

    The discovery could provide a foundation for developing medications that enhance the brain’s ability to adapt and reorganize itself, a property known as neuroplasticity. Such treatments might eventually offer new approaches for depression, post-traumatic stress disorder (PTSD), and other psychiatric conditions.

    The team also identified a particular group of neurons in the cerebral cortex that plays an essential role in psilocybin’s effects on brain connections. Importantly, the researchers discovered that the drug does not affect every brain in the same way. Its influence depends partly on whether the brain has previously experienced chronic stress. […]

    To investigate how psilocybin changes brain structure, the UC Santa Cruz team used an advanced imaging method called two-photon microscopy.

    This technology allows scientists to observe extremely small structures inside living tissue with remarkable detail. Using it, the researchers followed individual connections on neurons in living mice over several weeks, allowing them to see how those structures changed after psilocybin treatment.

    Their attention centered on tiny projections called dendritic spines. These structures extend from neurons and receive messages from neighboring nerve cells. They help form synapses, the specialized junctions through which neurons communicate.

    Synapses are essential for processing information and supporting functions such as learning, memory, and emotional regulation. Changes in their number, strength, and organization can alter the way information travels through the brain.

    Within just 24 hours of psilocybin administration, the researchers observed a substantial increase in newly forming dendritic spines.

    But the drug did more than encourage new connections to appear. It also helped them develop into more mature structures at an unusually rapid pace.

    Normally, newly formed spines often begin as small, immature structures described as “stubby.” Many remain unstable and disappear before becoming fully developed connections.

    After psilocybin treatment, however, a much larger proportion developed into structures with a distinctive “mushroom” appearance. These mature spines are generally more stable and contain higher concentrations of receptors that receive chemical signals from neighboring neurons. […]

    One of the study’s most revealing findings was that psilocybin’s influence on brain connections changed depending on whether the mice had experienced prolonged stress.

    In healthy mice, psilocybin initially stimulated the formation of new dendritic spines. Over the following three weeks, however, the number of connections gradually moved back toward its previous level.

    This happened partly because the brain eliminated some connections that had existed before treatment. Rather than simply accumulating additional synapses, the healthy brain appeared to reorganize its existing circuitry while maintaining an overall balance. […]

    The researchers observed a different response in mice exposed to chronic stress.

    To investigate this, they used an unpredictable mild stress model, which exposes animals to varying low-intensity stressors and produces changes that resemble certain features of human depression.

    Prolonged stress is known to interfere with neural communication and can cause substantial losses of synaptic connections. Over time, these changes can weaken the circuits involved in important brain functions.

    When the stressed mice received psilocybin, the researchers observed an especially strong increase in the formation of new dendritic spines.

    At the same time, psilocybin prevented the unusually high rate of connection loss associated with chronic stress.

    Together, these effects suggest that psilocybin may do more than temporarily increase the number of connections in the brain. Under stressful conditions, it may also help preserve existing connections and restore circuitry that has been disrupted. […]

    Perhaps the most significant implication of the research concerns a longstanding question in psychedelic medicine: Are hallucinations and altered states of consciousness necessary for the brain changes that might contribute to therapeutic benefits? […]

    The researchers focused on a group of nerve cells called Layer 5 pyramidal neurons. These cells are located in the cerebral cortex, the outer region of the brain involved in complex functions such as perception, reasoning, and decision-making.

    Layer 5 pyramidal neurons serve as important communication pathways that send information from the cortex to other brain regions. They also contain high levels of serotonin 2A receptors, making them especially relevant to understanding psilocybin’s effects.

    Using genetically modified mice, the team selectively changed whether these neurons possessed the receptors.

    The results revealed a striking separation between changes in brain connections and a behavior associated with psychedelic activity.

    When the researchers restored serotonin 2A receptors only in Layer 5 pyramidal neurons, psilocybin was still able to stimulate the development of new synapses and help stabilize them.

    Surprisingly, these mice did not display the characteristic head twitch response that researchers commonly use as an indicator of psychedelic activity in rodents. […]

    Funding came from the National Institute of Mental Health and the National Institute on Aging. The psilocybin used in the experiments was supplied through the National Institute on Drug Abuse (NIDA) Drug Supply Program. […]

    Science News: Magic mushrooms rewire the brain in a way scientists didn’t expect

    Nature Neuroscience: 5-HT2A receptors in layer 5 pyramidal neurons mediate the neuroplastic but not the hallucinogenic effects of psilocybin

    Authors: Jacob J. Baker, Emily Kogan, Shaorong Ma, Ju Lu, Yi Zuo.

  6. Servetus says:

    New funding from the federal government will prepare ibogaine for future medical use:

    Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers, and podcasters aligned with President Donald Trump.

    Health Secretary Robert F. Kennedy Jr. said his department is awarding up to $4.9 million to prepare for the first U.S. studies of ibogaine for post-traumatic stress disorder (PTSD), a hard-to-treat condition linked to higher suicide and substance abuse rates among veterans.

    The money will not go directly to patient research, Kennedy said, but to lay the groundwork needed to manufacture, dose, and design studies of the drug. […]

    Kennedy said the government will receive data and treatment guidance from Beond Inc., a Texas-based company that has treated more than 3,000 patients with ibogaine in Mexico, where the drug is not illegal.

    “That is going to allow us to dramatically accelerate the clinical trial process,” Kennedy said. “We’re going to have, I think, a record drug approval process.”

    Additional funding awards may explore ibogaine’s use for addiction, he said.

    Veterans Affairs Secretary Doug Collins, who joined Kennedy for the announcement, said the collaborative effort would focus first on safety and “best-in-class research.” […]

    Thursday’s announcement was previewed in April, when Trump signed an executive order directing federal agencies to speed up review and research of psychedelics that could help with mental health conditions.

    Three applications for psychedelics are pending review at the FDA. They include the first potential medicines made from psilocybin, the active ingredient in magic mushrooms, and MDMA, also called ecstasy. Decisions on those drugs could come within weeks or months.

    Because of its safety risks, ibogaine research has moved more slowly.

    The little data currently available mostly come from patients who have traveled to Mexico or other countries where ibogaine is not heavily regulated. Ibogaine clinics typically charge $10,000 to $20,000 for one course of treatment, which often involves monitoring of a patient’s heart readings while emergency medical workers are on standby.

    Trump’s order on psychedelics came after podcaster Joe Rogan said he texted Trump about ibogaine, which he repeatedly has discussed on his show. According to Rogan, the president quickly responded: “Sounds great. Do you want FDA approval? Let’s do it.” […]

    MedPage Today: Trump Officials Will Fund New Research on Controversial Psychedelic Drug Ibogaine — veterans groups, psychedelic advocates say the drug has great promise for mental heath conditions

Leave a Reply

Your email address will not be published. Required fields are marked *